Connor Clark & Lunn Investment Management Ltd. Trims Stake in Utah Medical Products, Inc. (NASDAQ:UTMD)

Connor Clark & Lunn Investment Management Ltd. lessened its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 55.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,603 shares of the medical instruments supplier’s stock after selling 5,734 shares during the period. Connor Clark & Lunn Investment Management Ltd. owned about 0.14% of Utah Medical Products worth $283,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Golden State Wealth Management LLC bought a new position in Utah Medical Products in the 4th quarter valued at $31,000. R Squared Ltd bought a new stake in Utah Medical Products during the 4th quarter valued at about $49,000. BNP Paribas Financial Markets boosted its position in Utah Medical Products by 102.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock valued at $75,000 after buying an additional 566 shares during the period. SG Americas Securities LLC purchased a new position in shares of Utah Medical Products during the fourth quarter worth approximately $157,000. Finally, Virtu Financial LLC bought a new stake in shares of Utah Medical Products during the third quarter valued at approximately $207,000. Institutional investors own 69.60% of the company’s stock.

Utah Medical Products Stock Down 1.0 %

Shares of NASDAQ:UTMD opened at $56.81 on Monday. The business’s 50 day moving average is $60.24 and its 200 day moving average is $63.14. The stock has a market cap of $192.70 million, a P/E ratio of 14.38 and a beta of 0.06. Utah Medical Products, Inc. has a 52-week low of $56.67 and a 52-week high of $77.33.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings data on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share (EPS) for the quarter. Utah Medical Products had a net margin of 33.92% and a return on equity of 11.07%.

Utah Medical Products Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 3rd. Shareholders of record on Friday, March 14th will be given a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a dividend yield of 2.15%. The ex-dividend date of this dividend is Friday, March 14th. Utah Medical Products’s payout ratio is 30.89%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.